BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29943882)

  • 1. The clinical outcome of LMNA missense mutations can be associated with the amount of mutated protein in the nuclear envelope.
    Al-Saaidi RA; Rasmussen TB; Birkler RID; Palmfeldt J; Beqqali A; Pinto YM; Nissen PH; Baandrup U; Mølgaard H; Hey TM; Eiskjaer H; Bross P; Mogensen J
    Eur J Heart Fail; 2018 Oct; 20(10):1404-1412. PubMed ID: 29943882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins.
    Al-Saaidi R; Rasmussen TB; Palmfeldt J; Nissen PH; Beqqali A; Hansen J; Pinto YM; Boesen T; Mogensen J; Bross P
    Exp Cell Res; 2013 Nov; 319(19):3010-9. PubMed ID: 24001739
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Hoorntje ET; Bollen IA; Barge-Schaapveld DQ; van Tienen FH; Te Meerman GJ; Jansweijer JA; van Essen AJ; Volders PG; Constantinescu AA; van den Akker PC; van Spaendonck-Zwarts KY; Oldenburg RA; Marcelis CL; van der Smagt JJ; Hennekam EA; Vink A; Bootsma M; Aten E; Wilde AA; van den Wijngaard A; Broers JL; Jongbloed JD; van der Velden J; van den Berg MP; van Tintelen JP
    Circ Cardiovasc Genet; 2017 Aug; 10(4):. PubMed ID: 28790152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene.
    Bonne G; Mercuri E; Muchir A; Urtizberea A; Bécane HM; Recan D; Merlini L; Wehnert M; Boor R; Reuner U; Vorgerd M; Wicklein EM; Eymard B; Duboc D; Penisson-Besnier I; Cuisset JM; Ferrer X; Desguerre I; Lacombe D; Bushby K; Pollitt C; Toniolo D; Fardeau M; Schwartz K; Muntoni F
    Ann Neurol; 2000 Aug; 48(2):170-80. PubMed ID: 10939567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional consequences of an LMNA mutation associated with a new cardiac and non-cardiac phenotype.
    Charniot JC; Pascal C; Bouchier C; Sébillon P; Salama J; Duboscq-Bidot L; Peuchmaurd M; Desnos M; Artigou JY; Komajda M
    Hum Mutat; 2003 May; 21(5):473-81. PubMed ID: 12673789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel mutations in LMNA associated with familial forms of dilated cardiomyopathy.
    Stallmeyer B; Koopmann M; Schulze-Bahr E
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):543-9. PubMed ID: 22224630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-Based Risk Stratification for Cardiac Disorders in
    Nishiuchi S; Makiyama T; Aiba T; Nakajima K; Hirose S; Kohjitani H; Yamamoto Y; Harita T; Hayano M; Wuriyanghai Y; Chen J; Sasaki K; Yagihara N; Ishikawa T; Onoue K; Murakoshi N; Watanabe I; Ohkubo K; Watanabe H; Ohno S; Doi T; Shizuta S; Minamino T; Saito Y; Oginosawa Y; Nogami A; Aonuma K; Kusano K; Makita N; Shimizu W; Horie M; Kimura T
    Circ Cardiovasc Genet; 2017 Dec; 10(6):. PubMed ID: 29237675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations.
    Sébillon P; Bouchier C; Bidot LD; Bonne G; Ahamed K; Charron P; Drouin-Garraud V; Millaire A; Desrumeaux G; Benaïche A; Charniot JC; Schwartz K; Villard E; Komajda M
    J Med Genet; 2003 Aug; 40(8):560-7. PubMed ID: 12920062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study.
    van Rijsingen IA; Arbustini E; Elliott PM; Mogensen J; Hermans-van Ast JF; van der Kooi AJ; van Tintelen JP; van den Berg MP; Pilotto A; Pasotti M; Jenkins S; Rowland C; Aslam U; Wilde AA; Perrot A; Pankuweit S; Zwinderman AH; Charron P; Pinto YM
    J Am Coll Cardiol; 2012 Jan; 59(5):493-500. PubMed ID: 22281253
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Kato K; Ohno S; Sonoda K; Fukuyama M; Makiyama T; Ozawa T; Horie M
    Circ Genom Precis Med; 2020 Oct; 13(5):435-443. PubMed ID: 32818388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients.
    Sylvius N; Bilinska ZT; Veinot JP; Fidzianska A; Bolongo PM; Poon S; McKeown P; Davies RA; Chan KL; Tang AS; Dyack S; Grzybowski J; Ruzyllo W; McBride H; Tesson F
    J Med Genet; 2005 Aug; 42(8):639-47. PubMed ID: 16061563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamin A/C gene mutations in familial cardiomyopathy with advanced atrioventricular block and arrhythmia.
    Saga A; Karibe A; Otomo J; Iwabuchi K; Takahashi T; Kanno H; Kikuchi J; Keitoku M; Shinozaki T; Shimokawa H
    Tohoku J Exp Med; 2009 Aug; 218(4):309-16. PubMed ID: 19638735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LMNA mutations in Polish patients with dilated cardiomyopathy: prevalence, clinical characteristics, and in vitro studies.
    Saj M; Bilinska ZT; Tarnowska A; Sioma A; Bolongo P; Sobieszczanska-Malek M; Michalak E; Golen D; Mazurkiewicz L; Malek L; Walczak E; Fidzianska A; Grzybowski J; Przybylski A; Zielinski T; Korewicki J; Tesson F; Ploski R
    BMC Med Genet; 2013 May; 14():55. PubMed ID: 23702046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel lamin A/C gene missense mutation (445 V > E) in immunoglobulin-like fold associated with left ventricular non-compaction.
    Liu Z; Shan H; Huang J; Li N; Hou C; Pu J
    Europace; 2016 Apr; 18(4):617-22. PubMed ID: 25829471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
    van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP;
    Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy.
    Parks SB; Kushner JD; Nauman D; Burgess D; Ludwigsen S; Peterson A; Li D; Jakobs P; Litt M; Porter CB; Rahko PS; Hershberger RE
    Am Heart J; 2008 Jul; 156(1):161-9. PubMed ID: 18585512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.
    Fatkin D; MacRae C; Sasaki T; Wolff MR; Porcu M; Frenneaux M; Atherton J; Vidaillet HJ; Spudich S; De Girolami U; Seidman JG; Seidman C; Muntoni F; Müehle G; Johnson W; McDonough B
    N Engl J Med; 1999 Dec; 341(23):1715-24. PubMed ID: 10580070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac effects of the c.1583 C→G LMNA mutation in two families with Emery-Dreifuss muscular dystrophy.
    Zhang L; Shen H; Zhao Z; Bing Q; Hu J
    Mol Med Rep; 2015 Oct; 12(4):5065-71. PubMed ID: 26165385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations.
    Taylor MR; Fain PR; Sinagra G; Robinson ML; Robertson AD; Carniel E; Di Lenarda A; Bohlmeyer TJ; Ferguson DA; Brodsky GL; Boucek MM; Lascor J; Moss AC; Li WL; Stetler GL; Muntoni F; Bristow MR; Mestroni L;
    J Am Coll Cardiol; 2003 Mar; 41(5):771-80. PubMed ID: 12628721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dilated cardiomyopathy caused by LMNA mutations. Clinical and morphological studies.
    Bilińska ZT; Sylvius N; Grzybowski J; Fidziańska A; Michalak E; Walczak E; Walski M; Bieganowska K; Szymaniak E; Kuśmierczyk-Droszcz B; Lubiszewska B; Wagner T; Tesson F; Ruzyłło W
    Kardiol Pol; 2006 Aug; 64(8):812-9; discussion 820-1. PubMed ID: 16981056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.